Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone vs Metformin in Obese Children With Insulin Resistance
NCT00775164Phase 4Withdrawn
- Sponsor
- University of Minnesota
- Start
- Jan 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of pioglitazone in obesity, insulin resistance (IR), sponsored by University of Minnesota. Planned start Jan 2009; status: withdrawn.
02
Drugs
pioglitazone
03
Conditions
obesityinsulin resistance (IR)
Beyond the preview
Go deeper on NCT00775164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00775164.